July 20, 2016
Dave Ricks to become Lilly's 11th CEO
Eli Lilly and Company announced that John C. Lechleiter, chairman, president and chief executive officer, will retire as president and CEO and from the company effective December 31, 2016. Lilly's board of directors unanimously elected Dave Ricks, currently senior vice president and president, Lilly Bio-Medicines, to assume the role of president and chief executive officer. Ricks is a Purdue alumnus and a member of the Weldon School of Biomedical Engineering advisory board.